Латвія - латвійська - Pārtikas un veterinārais dienests, Zemkopības ministrija

sensilab polska - tablete

Латвія - латвійська - Pārtikas un veterinārais dienests, Zemkopības ministrija

santamed ltd. - šķidrums

Латвія - латвійська - Pārtikas un veterinārais dienests, Zemkopības ministrija

labialfarma s.a. - kapsula

Європейський Союз - латвійська - EMA (European Medicines Agency)

ceva-phylaxia co. ltd. - live recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus (rfp-lt) and avian encephalomyelitis virus, strain calnek 1143 (ae) - immunologicals for aves, live viral vaccines, domestic fowl - cālis - for active immunisation of chickens of 8 to 13 weeks of age in order to reduce the skin lesions due to fowlpox, to reduce the clinical signs and tracheal lesions due to avian infectious laryngotracheitis and to prevent egg production losses due to avian encephalomyelitis.

Європейський Союз - латвійська - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - live recombinant marek’s disease virus, serotype 1, strain rn1250; live recombinant turkey herpesvirus, expressing the vp2 protein of infectious bursal disease virus, strain vhvt013-69 - immunologicals for aves, domestic fowl, avian herpes virus (marek's disease) + avian infectious bursal disease virus (gumboro disease) + newcastle disease virus/paramyxovirus - cālis - for active immunisation of one-day-old chicks to prevent mortality and clinical signs and reduce lesions caused by marek’s disease (md) virus (including very virulent md virus), and to prevent mortality, clinical signs and lesions caused by infectious bursal disease (ibd) virus.

Європейський Союз - латвійська - EMA (European Medicines Agency)

ceva-phylaxia co. ltd. - recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus, live - cālis - for active immunisation of chickens from 8 weeks of age in order to reduce the skin lesions due to fowlpox and to reduce the clinical signs and tracheal lesions due to avian infectious laryngotracheitis.

Європейський Союз - латвійська - EMA (European Medicines Agency)

takeda gmbh - dengue virus, serotype 2, expressing dengue virus, serotype 1, surface proteins, live, attenuated, dengue virus, serotype 2, expressing dengue virus, serotype 3, surface proteins, live, attenuated, dengue virus, serotype 2, expressing dengue virus, serotype 4, surface proteins, live, attenuated, dengue virus, serotype 2, live, attenuated - denges - vakcīnas - qdenga is indicated for the prevention of dengue disease in individuals from 4 years of age. the use of qdenga should be in accordance with official recommendations.

Латвія - латвійська - Zāļu valsts aģentūra

les laboratoires servier, france - atorvastatinum, perindoprili argininum, amlodipinum - apvalkotā tablete - 20 mg/5 mg/5 mg

Латвія - латвійська - Pārtikas un veterinārais dienests, Zemkopības ministrija

vitabiotics ltd. - tablete

Латвія - латвійська - Pārtikas un veterinārais dienests, Zemkopības ministrija

aptiekas produkcija, sia - tablete